Mechanisms and Therapeutic Strategies for Minority Cell-Induced Paclitaxel Resistance and Tumor Progression Mediated

Xueyan Feng1,2, Di Zhang1,2,3, Guoxun Wang3

  • 1State Key Laboratory for Structural Chemistry of Unstable and Stable Species, Institute of Chemistry, CAS Research/Education Center for Excellence in Molecular Sciences, Chinese Academy of Science, Beijing, 100190, P. R. China.

Insights

Minority-resistant cancer cells enhance tumor drug resistance and progression through mechanical force transmission, a process called mechano-assimilation. Disrupting this mechanical pathway can restore Paclitaxel sensitivity.

Area of Science:

  • Oncology
  • Biophysics
  • Cancer Biology

Background:

  • Chemotherapy resistance is a major challenge in cancer treatment, often driven by genetic mutations in a small population of resistant cells.
  • The mechanisms by which these minority-resistant cells (MRCs) drive resistance and tumor progression are not well understood.
  • Mechanical interactions between cancer cells are increasingly recognized as important factors in tumor behavior.

Purpose of the Study:

  • To investigate the mechanical pathways through which minority-resistant cancer cells (MRCs) promote drug resistance and tumor progression.
  • To explore the role of mechanical force transmission in the development and maintenance of Paclitaxel resistance.
  • To identify potential therapeutic strategies targeting mechanical interactions in cancer.

Main Methods:

  • Utilized force-induced remnant magnetization spectroscopy (FIRMS) combined with biological assays.
  • Characterized the mechanical properties of minority Paclitaxel-resistant cancer cells (MRCs) and sensitive cells (SCs).
  • Investigated the role of the force transducer Merlin in force transmission and mechano-assimilation.

Main Results:

  • Minority Paclitaxel-resistant cancer cells exhibit enhanced mechanical properties.
  • MRCs transmit high-intensity forces to surrounding SCs via Merlin, inducing 'mechano-assimilation'.
  • Mechano-assimilation accelerates drug resistance and tumor progression; its disruption restores Paclitaxel sensitivity in vitro and in vivo.

Conclusions:

  • Preliminary evidence suggests MRCs contribute to drug resistance and malignancy through mechanical interactions.
  • Mechano-assimilation is a novel mechanism driving cancer progression and resistance.
  • Targeting mechanical factors, like mechano-assimilation, offers a promising avenue for innovative cancer therapies.

Related Concept Videos

Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K
Cell-matrix's Response to Mechanical Forces01:13

Cell-matrix's Response to Mechanical Forces

In animal cells, the extracellular matrix allows cells within tissues to withstand external stresses and transmits signals from the outside of the cell to the inside. The extracellular matrix is extensive, and its composition varies between different types of tissues. For example, the reticular fibers and ground substance make up the ECM in loose connective tissue, while collagen and bone minerals make up the ECM of bone tissue. 
Anchoring junctions mechanically attach a cell to the...
2.6K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
Tension Response at Adherens Junctions01:26

Tension Response at Adherens Junctions

The adherens junctions that anchor cells together are multi-protein complexes that dynamically adapt to mechanical stimuli such as tensile forces and shear stress. Mechanosensory proteins in these junctions can sense such mechanical stimuli and undergo a shift in their conformation, resulting in an altered function — a process called mechanotransduction.
α-Catenin as a Mechanosensory Protein
The α-catenin of adherens junctions is an allosteric protein with three VH (vinculin...
2.6K
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
1.9K